ArticleCancer medicine2024

Efficacy of first-line dual oral pyrotinib plus capetabine therapy in HER2-positive metastatic breast cancer: A real-world retrospective study.

Shuang Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.